Home > Back to Publisher > Report Information

OTC Healthcare in Western Europe to 2011

Datamonitor
August 11, 2008
95 Pages - SKU: DFMN1872823

Abstract Table of Contents Search inside this report Related Reports

Countries covered: Europe

Introduction

This databook is a detailed information resource covering all the key data points on OTC Healthcare in Western Europe. It includes comprehensive value volume segmentation and market share data. The databook supplies actual data to 2006 and full forecasts to 2011 for 17 countries covered within the Western Europe region.

Scope

Contains information on:Analgesics,Cough & cold,Indigestion,Medicated skin products,Traditional medicines,Vitamins & Other OTC healthcare products
Provides market value, volume data by market, segment and sub segment

Highlights

The Western Europe OTC Healthcare market covering 17 countries, increased between 2001-2006, growing at an average annual rate of 2.3%.

The leading company in the market in 2006 was GlaxoSmithKline Plc. The second-largest player was Pfizer Inc with Bayer AG is third place.

Reasons to Purchase

Discover the major quantitative trends affecting the OTC Healthcare markets
Understand consumers' consumption and expenditure patterns for the 17 countries covered
Understand the future direction of the market with reliable historical data and full five year forecasting

Additional Information

Databooks are a detailed information resource covering all the key data points across all industry verticals. They provide data covering a particular market at country or regional level in comprehensive tabular and brief contextual format. The databook allows the user to study and analyze the data. This databook is comprised of an overview chapter covering the market as a whole, a chapter examining each category within the market, and a chapter containing socioeconomic analysis and data. It also includes a chapter detailing Datamonitor’s research methodology, and an appendix containing additional details.

Chapter 1 INTRODUCTION
: What is this report about?; How to use this report; Market Definition
Chapter 2 OVERVIEW
: Value Analysis
Chapter 3 WESTERN EUROPE OTC HEALTHCARE - MARKET OVERVIEW
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Company Share Analysis
Chapter 4 LEADING COMPANY PROFILES
: GlaxoSmithKline; Pfizer Inc
Chapter 5 CATEGORY ANALYSIS - ANALGESICS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Company Share Analysis
Chapter 6 CATEGORY ANALYSIS - COUGH AND COLD PREPARATIONS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Company Share Analysis
Chapter 7 CATEGORY ANALYSIS - TRADITIONAL MEDICINES
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Company Share Analysis
Chapter 8 CATEGORY ANALYSIS - FIRST AID KITS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Company Share Analysis
Chapter 9 CATEGORY ANALYSIS - INDIGESTION PREPARATIONS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Company Share Analysis
Chapter 10 CATEGORY ANALYSIS - VITAMINS AND MINERALS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Company Share Analysis
Chapter 11 CATEGORY ANALYSIS - PLASTERS & BANDAGES
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Company Share Analysis
Chapter 12 CATEGORY ANALYSIS - MEDICATED SKIN PRODUCTS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Company Share Analysis
Chapter 13 CATEGORY ANALYSIS - OTHER OTC HEALTHCARE PRODUCTS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Company Share Analysis
Chapter 14 CATEGORY ANALYSIS - TOPICAL OTC MEDICINES
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Company Share Analysis
Chapter 15 RESEARCH METHODOLOGY
: Methodology overview; Secondary research; Market modelling; Primary research; Data finalisation; Ongoing research
Chapter 16 APPENDIX
: Future readings; How to contact experts in your industry
LIST OF FIGURES
: Figure 1: Western Europe OTC Healthcare value & value forecast, 2001-2011 (US$ m, nominal prices); Figure 2: Western Europe OTC Healthcare category growth comparison, by value, 2001-2011; Figure 3: Western Europe OTC Healthcare company share (Top 5 companies), by value, 2005-2006 (%); Figure 4: Western Europe Analgesics value & value forecast, 2001-2011 (US$ m, nominal prices); Figure 5: Western Europe Analgesics category growth comparison, by value, 2001-2011; Figure 6: Western Europe Analgesics company share (Top 5 companies), by value, 2005-2006 (%); Figure 7: Western Europe Cough and Cold Preparations value & value forecast, 2001-2011 (US$ m, nominal prices); Figure 8: Western Europe Cough and Cold Preparations category growth comparison, by value, 2001-2011; Figure 9: Western Europe Cough and Cold Preparations company share (Top 5 companies), by value, 2005-2006 (%); Figure 10: Western Europe Traditional Medicines value & value forecast, 2001-2011 (US$ m, nominal prices); Figure 11: Western Europe Traditional Medicines company share (Top 5 companies), by value, 2005-2006 (%); Figure 12: Western Europe First Aid Kits value & value forecast, 2001-2011 (US$ m, nominal prices); Figure 13: Western Europe First Aid Kits company share (Top 5 companies), by value, 2005-2006 (%); Figure 14: Western Europe Indigestion Preparations value & value forecast, 2001-2011 (US$ m, nominal prices); Figure 15: Western Europe Indigestion Preparations category growth comparison, by value, 2001-2011; Figure 16: Western Europe Indigestion Preparations company share (Top 5 companies), by value, 2005-2006 (%); Figure 17: Western Europe Vitamins and Minerals value & value forecast, 2001-2011 (US$ m, nominal prices); Figure 18: Western Europe Vitamins and Minerals category growth comparison, by value, 2001-2011; Figure 19: Western Europe Vitamins and Minerals company share (Top 5 companies), by value, 2005-2006 (%); Figure 20: Western Europe Plasters & Bandages value & value forecast, 2001-2011 (US$ m, nominal prices); Figure 21: Western Europe Plasters & Bandages category growth comparison, by value, 2001-2011; Figure 22: Western Europe Plasters & Bandages company share (Top 5 companies), by value, 2005-2006 (%); Figure 23: Western Europe Medicated Skin Products value & value forecast, 2001-2011 (US$ m, nominal prices); Figure 24: Western Europe Medicated Skin Products category growth comparison, by value, 2001-2011; Figure 25: Western Europe Medicated Skin Products company share (Top 5 companies), by value, 2005-2006 (%); Figure 26: Western Europe Other OTC Healthcare Products value & value forecast, 2001-2011 (US$ m, nominal prices); Figure 27: Western Europe Other OTC Healthcare Products category growth comparison, by value, 2001-2011; Figure 28: Western Europe Other OTC Healthcare Products company share (Top 5 companies), by value, 2005-2006 (%); Figure 29: Western Europe Topical OTC Medicines value & value forecast, 2001-2011 (US$ m, nominal prices); Figure 30: Western Europe Topical OTC Medicines category growth comparison, by value, 2001-2011; Figure 31: Western Europe Topical OTC Medicines company share (Top 5 companies), by value, 2005-2006 (%); Figure 32: Annual data review process
LIST OF TABLES
: Table 1: OTC Healthcare category definitions; Table 2: Western Europe OTC Healthcare value (country-wise), 2001-2006 (US$ m, nominal prices); Table 3: Western Europe OTC Healthcare value (country-wise) forecast, 2006-2011 (US$ m, nominal prices); Table 4: Western Europe OTC Healthcare value, 2001-2006 (US$ m, nominal prices); Table 5: Western Europe OTC Healthcare value forecast, 2006-2011 (US$ m, nominal prices); Table 6: Western Europe OTC Healthcare company share (Top 20 Companies) by value, 2005-2006 (%); Table 7: Western Europe OTC Healthcare value, by company, 2005-2006 (US$ m nominal prices); Table 8: GlaxoSmithKline Key Facts; Table 9: Pfizer Inc Key Facts; Table 10: Western Europe Analgesics value, 2001-2006 (US$ m, nominal prices); Table 11: Western Europe Analgesics value forecast, 2006-2011 (US$ m, nominal prices); Table 12: Western Europe Analgesics company share (Top 20 Companies) by value, 2005-2006 (%); Table 13: Western Europe Analgesics value, by company, 2005-2006 (US$ m nominal prices); Table 14: Western Europe Cough and Cold Preparations value, 2001-2006 (US$ m, nominal prices); Table 15: Western Europe Cough and cold preparations value forecast, 2006-2011 (US$ m, nominal prices); Table 16: Western Europe Cough and Cold Preparations company share (Top 20 Companies) by value, 2005-2006 (%); Table 17: Western Europe Cough and Cold Preparations value, by company, 2005-2006 (US$ m nominal prices); Table 18: Western Europe Traditional Medicines value, 2001-2006 (US$ m, nominal prices); Table 19: Western Europe Traditional Medicines value forecast, 2006-2011 (US$ m, nominal prices); Table 20: Western Europe Traditional Medicines company share (Top 20 Companies) by value, 2005-2006 (%); Table 21: Western Europe Traditional Medicines value, by company, 2005-2006 (US$ m nominal prices); Table 22: Western Europe First Aid Kits value, 2001-2006 (US$ m, nominal prices); Table 23: Western Europe First Aid Kits value forecast, 2006-2011 (US$ m, nominal prices); Table 24: Western Europe First Aid Kits company share (Top 20 Companies) by value, 2005-2006 (%); Table 25: Western Europe First Aid Kits value, by company, 2005-2006 (US$ m nominal prices); Table 26: Western Europe Indigestion Preparations value, 2001-2006 (US$ m, nominal prices); Table 27: Western Europe Indigestion Preparations value forecast, 2006-2011 (US$ m, nominal prices); Table 28: Western Europe Indigestion Preparations company share (Top 20 Companies) by value, 2005-2006 (%); Table 29: Western Europe Indigestion Preparations value, by company, 2005-2006 (US$ m nominal prices); Table 30: Western Europe Vitamins and Minerals value, 2001-2006 (US$ m, nominal prices); Table 31: Western Europe Vitamins and Minerals value forecast, 2006-2011 (US$ m, nominal prices); Table 32: Western Europe Vitamins and Minerals company share (Top 20 Companies) by value, 2005-2006 (%); Table 33: Western Europe Vitamins and Minerals value, by company, 2005-2006 (US$ m nominal prices); Table 34: Western Europe Plasters & Bandages value, 2001-2006 (US$ m, nominal prices); Table 35: Western Europe Plasters & Bandages value forecast, 2006-2011 (US$ m, nominal prices); Table 36: Western Europe Plasters & Bandages company share (Top 20 Companies) by value, 2005-2006 (%); Table 37: Western Europe Plasters & Bandages value, by company, 2005-2006 (US$ m nominal prices); Table 38: Western Europe Medicated Skin Products value, 2001-2006 (US$ m, nominal prices); Table 39: Western Europe Medicated Skin Products value forecast, 2006-2011 (US$ m, nominal prices); Table 40: Western Europe Medicated Skin Products company share (Top 20 Companies) by value, 2005-2006 (%); Table 41: Western Europe Medicated Skin Products value, by company, 2005-2006 (US$ m nominal prices); Table 42: Western Europe Other OTC Healthcare Products value, 2001-2006 (US$ m, nominal prices); Table 43: Western Europe Other OTC Healthcare Products value forecast, 2006-2011 (US$ m, nominal prices); Table 44: Western Europe Other OTC Healthcare Products company share (Top 20 Companies) by value, 2005-2006 (%); Table 45: Western Europe Other OTC Healthcare Products value, by company, 2005-2006 (US$ m nominal prices); Table 46: Western Europe Topical OTC Medicines value, 2001-2006 (US$ m, nominal prices); Table 47: Western Europe Topical OTC Medicines value forecast, 2006-2011 (US$ m, nominal prices); Table 48: Western Europe Topical OTC Medicines company share (Top 20 Companies) by value, 2005-2006 (%); Table 49: Western Europe Topical OTC Medicines value, by company, 2005-2006 (US$ m nominal prices)

More Europe Over-the-Counter Drugs Reports

Medicated Skin Care in the Czech Republic by Euromonitor International
Sales of medicated skin care over the review period were driven by hectic lifestyle and worsening environment which brought negative repercussions on health of consumers, ...

Herbal/Traditional Products in the Czech Republic by Euromonitor International
Herbal/traditional products has value growth of 2% in 2011. This performance was lower compared to review period CAGR as consumers were more careful with money ...

Ear Care in the Czech Republic by Euromonitor International
Ear care is a niche market, with retail value sales of CZK13 million in 2011. Although ear care had dynamic growth at the beginning of ...

Digestive Remedies in the Czech Republic by Euromonitor International
Digestive remedies had value growth of 1% in 2011 which was only slightly lower compared to review period value CAGR. Sales of digestive remedies were ...

Cough, Cold and Allergy (Hay Fever) Remedies in the Czech Republic by Euromonitor International
Cough, cold and allergy remedies had the highest value in OTC with CZK2.7 billion in 2011. Cold and flu are common illnesses and many consumers ...

See all reports like this >>

More Europe Reports

A Comprehensive Study Of The UK Video Conferencing Equipment Market In 2010, Rating & Valuing Each Of The 30 Companies That Operate In Today's Market by Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...

A Comprehensive Study Of The UK Tableware Market In 2010, Rating & Valuing Each Of The 166 Companies That Operate In Today's Market by Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...

A Comprehensive Study Of The UK Surveyors & Valuers Market In 2010, Rating & Valuing Each Of The 943 Companies That Operate In Today's Market by Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...

A Comprehensive Study Of The UK Subsea Engineering Market In 2010, Rating & Valuing Each Of The 142 Companies That Operate In Today's Market by Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...

A Comprehensive Study Of The UK Structural Engineering Consultancy Market In 2010, Rating & Valuing Each Of The 300 Companies That Operate In Today's Market by Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...

See all reports like this >>

OTC Healthcare in Western Europe to 2011

Share this report

Other tasks

Research Assistance

Related Markets

Over-the-Counter Drugs Reports

Free Alert Me service